Pluri Inc.

US$1.24As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PLURHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (36.87%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.65
PE TTM —
TSR TTM (68.33%)
Mkt cap US$15.25M
ROIC (61.53%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.18
(4.64%)
(94.02%)
Hold 6|4|6|10|1
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.02
0.02
0.02
0.02
29.39%
21.31%
16.12%
12.02%
Revenue$M
0.813
0.806
0.805
0.824
18.45%
11.78%
8.81%
7.24%
Peers (US$15.25M)
Cap (US$)
PE
10.13M
—
Capital
TTM
5Y
10Y
Leveragex
15.42
(0.902)
(0.740)
EBIT/Intx
7.677
0.067
0.068
Own earn%
62.66
(41.73)
(39.93)
Sh yield%
52.49
48.63
45.30
Owners
Insiders/Inst%
14.80
59.85
Short interest%
5.36
SBC / revenue%
2.08
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
16–24
$1 testx
0.4
Incr. ROIC%
2